InvestorsHub Logo
Followers 124
Posts 3153
Boards Moderated 1
Alias Born 08/11/2022

Re: Money hunt post# 1288

Tuesday, 05/07/2024 8:08:59 PM

Tuesday, May 07, 2024 8:08:59 PM

Post# of 2032
New hope for terminally ill cancer patients
We know of no other RNA companies currently in clinical development that have an exclusive focus on cancer and whose pipelines are not limited to a single RNA technology such as siRNA or mRNA vaccines. By contrast, TransCode’s pipeline spans a spectrum of RNA technologies and includes ncRNAs, RNA vaccines, CRISPR technology, and immunostimulatory RNAs solely for oncology
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RNAZ News